Using Artificial Intelligence to Advance the Research and Development of Orphan Drugs

• Published in: Businesses Vol. 4; no. 3; pp. 453 - 472
• Main Authors: Irissarry, Carla, Burger-Helmchen, Thierry
• Format: Journal Article
• Language: English
• Published: Hawthorn MDPI AG 09.09.2024; MDPI
• Subjects: Artificial intelligence; business; Business administration; Clinical trials; Drug development; drug discovery and industry; Human subjects; Humanities and Social Sciences; Machine learning; Medical research; Monetary incentives; orphan drug; Pathogenesis; Pharmaceutical industry; R&D; rare disease; Rare diseases; Research & development; United States > US; Clinical and virtual trials; Health economics; Drug discovery and industry; Rare disease; Financial risk; AI; Development; Research; Orphan drug; Business; Treatment success

While artificial intelligence has successful and innovative applications in common medicine, could its application facilitate research on rare diseases? This study explores the application of artificial intelligence (AI) in orphan drug research, focusing on how AI can address three major barriers: h...